The Food and Drug Administration (FDA) is announcing a public Workshop entitled “Clinical Considerations of Risk in the Postmarket Environment.” The purpose of the workshop is to provide a forum for an interactive discussion on assessing changes in medical device risk as quality and safety situations arise in the postmarket setting when a patient, operator,…
FDAVoice: Providing Timely Patient Access to High-Quality, Safe and Effective Medical Devices
Jeffrey Shuren, M.D., J.D. We know that patients with life-threatening or irreversibly debilitating conditions lack treatment and diagnostic options. For these patients, earlier access to promising new devices is critically important. At the same time, delayed access may mean the difference between life and death, or may result in irreversible disability. In weighing the benefits…
Expedited Access Pathway Program
The Expedited Access Pathway (EAP) program is a voluntary program for certain medical devices that demonstrate the potential to address unmet medical needs for life threatening or irreversibly debilitating diseases or conditions that are subject to premarket approval applications (PMA) or are eligible for de novo requests. The program is detailed in the FDA’s guidance…
Balancing Premarket and Postmarket Data Collection for Devices Subject to Premarket Approval
%PDF-1.7 % 1047 0 obj stream
Expedited Access for Premarket Approval and De Novo Medical Devices Intended for Unmet Medical Need for Life Threatening or Irreversibly Debilitating Diseases or Conditions
%PDF-1.7% 4091 0 objstream hko7JL(bN`ad{Ma1’Nd4nsedgq8]4″”^nhσ!AP A|$_0!_bԒ8Rը!eY:P톢NUUiyN5-!EG)AiU5STMluHNPh5yӬ$#MRJէnV}MZɃv;NuPVxϤOUC^9FꧠTUj:,j”Ofh5gOWEOWoWoWoԎC:V?UtpjzV]P?ԦϖtFҫϽh6 enf%$ަP+t/j^$g]jڙN6Y*ü*P)kEۨdfsoj}|٥-SM”-ܫV)tޔ`ΜMNAtfo6[ 66b}tFIJU]NUӫ.’pצ!if6gfmҬWDz6:Č0bNQk:Lke :EL:KNfp5@qz”q솎ѓ͐Wmn;5S:ۜVBT4phb!CVBE!fU[XXM94P’45mR3h~bRQ[qzA[ulmلkD{edv6ӀaoԠaы Erj6u8n08;,0#jU2)Ug3-oE(0F80Fgam|wa|0’G4ۤ՛hC8{.3lC’E0{U6I[w?}ѳe/?D?{`Kpkn%KtoKC?’fŦ-5?;_Y^^v٫WW[{~wTWta*ݲ)i߿azk1m/m+-xHi5bJ=Qi4;SMi:4˨گMWg~|[Lk?.}’1Kq8:{lݽPSA)n4X{uG/CJ)mcQlN`B?=_8=ӣ”0virlf獚ggG~ܟ75For|^#tܧN:b7sN=7Os:Os:Os:mXCQv6wCQm0ZӚ{/ǁTPTkejkmDg1p+nݭ1{[dr1H=1CZ2Pph)^2=63t7ҷsqFh)|Q|zh%,[2[Ql?oOeVG7aEF}Au^3d5`v’SCqyfST|?SǠVASǽbG[LKCޘg:6O:N2ԍe~W}_ɋ7˫onfqѣ_vr~x])zzyyv#Wx9~Yr4uhUwu=/%N[o润9/N헦ߙj1q ;F˛CBe~Io S’OwG}7减c_68GXq=NBqܼymȜ?lz2X7#oaPxcԿL6c{4mZގo3eq#q4헪x?S߶Gnٺ3{mlry̽%FlBU*ϸ~zwgt3-fF2K;jo ~ۿ}’/vbQ){=~?]_l0y[@(6vl-ⶂMSmBag|{@(݆ԝ :j{/yZ?ΗfF?/IS:〸)z N #D^,3@9|ϨŗO=yu00G,/^-.ʝj[q-?wb3}iidI4ko’62Dܱ ‘ܜBBa ~C?ۏDBDnTYRKs9J$ PdGfشGukw7A}{g{n}~vV’?~8~q_~b}zlu֎rg7vNj-^RzҼcY:,gO^:|֫a1嫳6uuS/:ۄDjנ:uWg/sm|XT.{uwne{./;M{]s6j]fax~N 賗4/~]՜]]o^*{S;;۳fplBrrxNT/’wvm~YԹtzCa)Bتzv{YnV,zWi;”\ѩ8w-{Gy3֥Xï3S}O7[36bnrʛדCm;#Zގh?2vzBA=d9|}UNTimo}:?_sIlTٛ+k[q4#ݫ?zru5ж~!rx]Mz8??_qk7|:J8 vNYt%x-ffy$wWM껣`ƣΥ}mmfna븱Yy횸}6iEL4X’ή֗|Ƕix’_/O~Ӌ?:׆VWlw”ޝNOwfBqb;jgx[pQ[Ae{K7OC@o!ΕO|^8ymwdÞaC?46}))`5ٳ=E{.S#)Gw”_%VlS=ۮշifpI;/Ȗ509o]’ޤg6.V[VeԊa{zJIkiܜZ|Oc{*23nNdÇ8X}J}ؗ)9S,V{+Nkъ7X7zŊ7Yz͊LzZOM~Z/V른^蔱[D Mq{wXWZ)VkwGZ%+xڴg+k˚v[/MqT@[qVlrzS(X/^? ˶k`Gzv{䣠lfq8:+]^Fwkw]_h(ۛ+L{_aWg2tM|d=6T7JZjWjrdUKYKW%ZlGb~:O_W1-30! BELJAz*z8p ’57@uh1!}!”$;Ag4zwTrʞꜱȁ2RWʑws;w$ށ;̙w2d’r;o^鉏ndt#I”C” P8x’Ǽa0$bÜiMnTg 93)PNN͌wJx;wʼx’9̎dEZn12#ÌA11Xa#S2$ckT$X3z`#lxdFhĶDHHHOb|DdvDNDIdDfG$,ĀKN|`X#?n!@=D@4D@4
Agenda posted for April 17, 2015 Neurological Devices Panel of the Medical Devices Advisory Committee
%PDF-1.7 % 56 0 obj stream xyMǿIȾ31CTRRcP RcjȒ0HC֏y|̹۹u~˼x=y{9YYYs!B!D$(!B!!W{^B!BB!B!yzE!B!ZzE!B!ZzE!B!Z_B!BHQ^BC”B!B”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”B!@”RokX-F϶BQ|K”Rȑ/aTK*!hdK”RɃJh2 |U@QBɖzE!ТeP,”)-BH!’*E(YTEQZ)B:-BH!M?~|۷oyZīWRSS;/^FO8pP˗/8DPˇ4jTFFQ^ fUZJql80)?*5BHхzE!h;vu8ϓ’O^u”SNXq ݃A=|:{, CǎCIII?=:*ٳ7n;wG?~QGFF*Bqqqoƞ,ݭUzTzE!hˀ===]EyD,X
Consumer Information on: Medtronic CoreValve System
This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval. Product Name: Medtronic CoreValve SystemPMA Applicant: Medtronic…
Webinar Presentation and Transcript Added to Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling Final Guidance
<!– –> <!– Page Last Updated: 04/01/2015 –> Page Last Updated: 04/01/2015 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Consumer Information on: WATCHMAN LAA Closure Technology
This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval. Product Name: WATCHMAN LAA Closure TechnologyPMA Applicant:…
Procedures for Meetings of the Medical Devices Advisory Committee – Draft Guidance for Industry and Food and Drug Administration Staff (PDF
%PDF-1.6% 701 0 objstream hmO0}٤Qĉ UkahLM5e~wvowg=w$*”$KH$a6DI”C=ATIl@ 71A)4D$VC~Ze’eQ}Q}OŨɋ1EII:’qVm]mг1ݯmF/w٥eO7у[QVDN{ck@P(I8(f’d+M_^ı:”CL*Y9e3cNWa,K1}~M]:6YfKy9!rF,!7v!m’^MۖRj^vm^o